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A B S T R A C T
In 2010, there were roughly 219 million cases of malaria reported worldwide resulting in an estimated
660,600 deaths [1]. In contrast, the total number of cases according to the Centers for Disease Control and
Prevention (CDC) in the United States (USA) was only 1691 [2]. Of those, 1688 were cases of imported
malaria [2]. This is the highest number of cases reported in U.S. since 1980 [2]. Here, we describe a case of
imported malaria and conduct a retrospective case series at four Connecticut (CT) hospitals in order to
describe the demographics of imported malaria and to identify potential barriers to timely diagnosis and
treatment.
 2014 he Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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In 2010, there were roughly 219 million cases of malaria
reported worldwide resulting in an estimated 660,600 deaths [1].
In contrast, the total number of cases according to the Centers for
Disease Control and Prevention (CDC) in the United States (USA)
was only 1691 [2]. Of those, 1688 were cases of imported malaria
[2]. This is the highest number of cases reported in U.S. since 1980
[2]. Here, we describe a case of imported malaria and conduct a
retrospective case series at four Connecticut (CT) hospitals in order
to describe the demographics of imported malaria and to identify
potential barriers to timely diagnosis and treatment.
Case report
A 24-year-old African-American female college student with no
signiﬁcant past medical history presented to the emergency room
with fever, lower abdominal pain and nausea without vomiting
starting the day prior to admission. She noted that her menstrual
period was slightly late, but otherwise the history obtained was
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She had an episode of vaginal bleeding while being evaluated. As a
result, a pelvic examination was performed, which was unremark-
able aside from scant blood in the vaginal canal and a closed cervix.
Beta-HCG was obtained and was elevated at 784. Ultrasound of the
abdomen and pelvis demonstrated a fetal sac in the uterus, but was
otherwise within normal limits. Routine diagnostic testing was
notable for a normal white blood count, normal hemoglobin, low
platelets (92,000), normal kidney function (Cr 0.6), mild transa-
minitis (ALT 84, AST 72) and an indirect hyperbilirubinemia (TB
1.4, DB 0.3). Urinalysis demonstrated 5–6 WBCs, 9–10 RBCs, 10–12
epithelial cells, 1+ bacteria and trace leukocytes.
She was subsequently admitted to the medical service with the
diagnosis of UTI and threatened abortion and was started on
nitrofurantoin and IV ﬂuids. Overnight, she spiked a high fever
(104 F) with rigors. Morning laboratory investigations revealed a
new leukopenia (WBC 2.8) and worsening thrombocytopenia (Plt
66,000). As a result, OB/Gyn was consulted for concern for possible
septic abortion. They determined that it was an inevitable abortion
and antibiotics were broadened. Given her worsening septic
picture, infectious disease was consulted, a peripheral blood smear
sent and doxycycline started for concern of ehrlichiosis. During the
infectious disease evaluation, it is discovered that both the patient
and her husband had recently traveled to Nigeria, her husband had
been infected with malaria during their visit there, and she herselfder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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become so ill en route that she presented to the emergency room
directly from the airport.
Subsequently, the peripheral smear was reviewed by the ID
attending in the laboratory and intracellular ‘ear muff’ shaped
parasites consistent with Plasmodium falciparum were seen. As a
result, the patient was diagnosed with uncomplicated malaria
given no evidence of complications meeting criteria for severe
malaria (namely, severe anemia, renal failure, ARDS, and hyper-
parasitemia) [3]. The CDC was contacted with respect to
Artemisinin-based combination treatment. However, the decision
was made to treat immediately with atovaquone/proguanil given
that it was more readily available from an outside pharmacy than
waiting for Artemisinin-based medication sent directly from the
CDC. It was not until the third day of hospitalization that she
received appropriate treatment. With anti-malarials, her clinical
condition improved and she defervesced over the next 48 h. She
was eventually discharged home after a six-day admission.
Retrospective case series
We conducted a retrospective case series of all patients with
conﬁrmed diagnosis of malaria from 2001 to 2012 at four
Connecticut teaching hospitals (Waterbury Hospital, St. Mary’s
Hospital, Hospital of St. Raphael, & Grifﬁn Hospital) in order to
describe the demographics of imported malaria and to identify
potential barriers to timely diagnosis and treatment.
Of a total of the fourteen patients, 54% were African, 23%
American, 16% South Asian and 8% Hispanic. Most patients were
foreign residents visiting the USA (54%), while the rest were USA
citizens. A vast majority of patients were traveling in sub-Saharan
Africa (73%, 9% India, 9% Pakistan, 9% Dominican Republic). Only a
minority of patients took anti-malarial prophylaxis (22%). Symp-
toms began on average 3.1 days (range 1–8, SD 2.8) after arrival to
the USA and patients presented to a healthcare provider on average
4.7 days (range 0–37, SD 12.1) after onset of symptoms. At the time
of presentation, malaria was on the differential diagnosis in only
half of cases and travel history was documented in only 69% of
cases. Mean time to diagnosis was 2.9 days (range 0–12, SD 3.6).
The vast majority of cases were due to P. falciparum (92%), while
the remaining case was due to Plasmodium vivax. In general,
parasite burden was low with 75% of cases with 2% parasitemia.
Appropriate treatment was initiated in 93% of cases and mean
time to treatment from time of presentation was 3.0 days (range 0–
12, SD 3.6). Anti-malarial medications were available in the
hospital pharmacy for only half of the cases. For these patients,
treatment was administered promptly (mean 2.2 h, range 1–3 h).
In cases where medications were not available in the hospital,
there was a signiﬁcant time delay between when the drug was
ordered and when it was administered with 75% of patients
receiving treatment 8 h (mean 10.3 h, range 7–12 h) after it was
ordered. In general, patients responded well to treatment. 71%
were admitted to the hospital and only one case required ICU
admission. Patients requiring inpatient admission were hospital-
ized on average for 3.2 days (range 1–7, SD 1.9).
Discussion
Internationally, malaria is a life-threatening infectious disease
resulting in as many as 500 million estimated cases annually [4]. In
contrast, domestically, malaria is no longer endemic and instead is
imported via international travel and immigration from afﬂicted
parts of the world. According to Department of Homeland Security,
about 12,000 people obtained legal residence in Connecticut
during 2011. In comparison, the bordering state of New York had
close to 150,000 legal immigrants out of a total of just over 1million for the US as a whole [5]. With regards to malaria,
Connecticut had a total of 21 reported cases compared to the 1691
nationwide in 2010 [2]. The incidence of malaria in Connecticut is
comparable to that of the US (0.6 vs. 0.5 cases of malaria per
100,000 people, respectively) [2,6,7]. Given the rise of globaliza-
tion, the number of cases of malaria has increased proportionally in
the US. According to the CDC, the number of cases of malaria in
2010 was a 30% increase compared to 2008 and a 14% increase
compared to 2009 [2]. Similarly, the United Kingdom reported a
29% increase of malaria cases from 2008 to 2010 [2].
Several possible factors have been identiﬁed for the delay in
diagnosis and treatment of imported malaria. In 2000, Dorsey et al.
reviewed 121 conﬁrmed cases of malaria over a 10-year period in
San Francisco, California and found that in 19 (16%) of these cases
the initial physician missed the diagnosis of malaria [8]. The
authors suggested the delayed diagnosis might be attributed to an
incomplete travel history. Similarly, our analysis determined that
in 31% of imported malaria cases a travel history was not
documented and in half of the cases malaria was not considered
on the differential diagnosis. In 1998, Kain et al. performed a
prospective analysis of the diagnosis and treatment of malaria in
Toronto, Canada [9]. In that study, the correct initial diagnosis was
not made in 59% of cases and there was a delay in treatment for
cases of P. falciparum by about 7 days [9]. In our series, the mean
time to treatment was also delayed until approximately 3 days
after presentation to a healthcare provider. Furthermore, these
treatment delays were often exacerbated by the unavailability of
anti-malarials in hospital pharmacies. Lastly, the CDC has long
recommended chemoprophylaxis against malaria. However, only a
minority of travelers is compliant with prophylactic medications
[4,8,9]. Similarly, in our results, only about one-ﬁfth of the patients
took anti-malarial prophylaxis.
In conclusion, imported malaria is relatively uncommon in the
US, but each year the number of cases continues to rise given
trends in globalization and international travel [8]. However, when
these cases presented to the healthcare system, malaria was not
entertained on the differential diagnosis, travel history was not
obtained, chemoprophylaxis was underutilized, and anti-malarials
were not available in hospital pharmacies in substantial proportion
of these cases resulting in possible delays in diagnosis and
treatment. Based on these ﬁndings, we wish to re-emphasize and
recommend that:
1. All individuals traveling to malaria endemic parts of the world
be evaluated by a travel clinic prior to departure and to stress the
importance of anti-malarial prophylaxis;
2. All healthcare providers must maintain a broad differential
diagnosis and take a thorough travel history given that imported
tropical diseases will become more commonplace in the setting
of globalization in order to prevent delays in diagnosis;
3. All healthcare provides should be familiar with trends in global
health in order to be informed of the growing mobility and the
evolving epidemiology of infectious diseases;
4. All hospital pharmacies should have anti-malarial medications
stocked to allow for prompt treatment of this life-threatening
infectious disease.
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